Pharmacological interventions for geriatric cachexia: A narrative review of the literature
- 366 Downloads
The objective of this review was to investigate the range of pharmacological interventions that have been studied for treatment of geriatric cachexia, and to evaluate their effect on selected clinical outcomes in this population.
Databases including Medline and Cochrane Central Register of Controlled Trials were searched up to March 2010 with search terms including “cache*”, “intervention”, “megestrol acetate” and “cytokine inhibitors”. Studies investigating subjects with mean age <60y or disease-related cachexia were excluded. Outcomes assessed were weight or BMI, body composition, appetite and laboratory parameters indicative of cachexia.
Fifteen publications met the selection criteria, reporting on ten studies. Seven studies investigated use of megestrol acetate (MA): two randomised controlled trials, one case control study, two pre-test/post-test studies and two retrospective chart reviews. Weight/BMI was common amongst outcomes and these studies showed an improvement in weight compared with baseline. MA studies which investigated body composition, appetite and/or laboratory parameters provided some evidence for improvement in these outcomes. Three randomised controlled trials investigated the use of other interventions: ghrelin, growth hormone and vitamin supplementations. All demonstrated a significant increase in lean body mass. The only other outcome of interest in these three trials was weight in one study with a significant increase demonstrated.
Little investigation has been conducted in this population and the diagnosis of cachexia is problematic however these trials provide preliminary evidence for beneficial outcomes in older adults likely to have cachexia. Further high quality adequately powered prospective studies are necessary to provide effective treatment for geriatric cachexia.
Key wordsGeriatrics cachexia therapeutics review treatment outcome nutrition
Unable to display preview. Download preview PDF.
- 9.Milne AC, Potter J, Vivanti A, and Avenell A (2009) Protein and energy supplementation in elderly people at risk from malnutrition.[update of Cochrane Database Syst Rev. 2005;(2):CD003288; PMID: 15846655]. Cochrane DB Syst Rev:CD003288.Google Scholar
- 16.Yeh S, Wu SY, Levine DM, Parker TS, Olson JS, Stevens MR, and Schuster MW (2000) Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome. J Nutr Health Aging 4:246–251.PubMedGoogle Scholar
- 17.Yeh SS, Wu SY, Lee TP, Olson JS, Stevens MR, Dixon T, Porcelli RJ, and Schuster MW (2000) Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study.[see comment]. J Am Geriatr Soc 48:485–492.PubMedGoogle Scholar
- 21.Karcic E, Philpot C, and Morley J (2000) Megestrol acetate treatment in older persons in long-term care facilities. J Invest Med 48:261.Google Scholar
- 23.Bodenner D, Spencer T, Riggs AT, Redman C, Strunk B, and Hughes T (2007) A retrospective study of the association between megestrol acetate administration and mortality among nursing home residents with clinically significant weight loss. Am J Geriatr Pharmacother 5:137–146.PubMedCrossRefGoogle Scholar
- 28.Akamizu T, Iwakura H, Ariyasu H, Murayama T, Sumi E, Teramukai S, Goto K, Ohnishi E, Akiyama H, Kawanabe K, Nankaku M, Ichihashi N, Tsuboyama T, Tamai K, Kataoka M, Nakamura T, Kangawa K, and Osteoarthritis-Total Hip Replacement Clinical Study T (2008) Effects of ghrelin treatment on patients undergoing total hip replacement for osteoarthritis: different outcomes from studies in patients with cardiac and pulmonary cachexia. J Am Geriatr Soc 56:2363–2365.PubMedCrossRefGoogle Scholar
- 31.National Health and Medical Research Council (2008) NHMRC additional levels of evidence and grades for recommendations for developers of guidelines — Stage 2 Consultation paper. http://www.nhmrc.gov.au/_files_nhmrc/file/guidelines/Stage %202%20Consultation% 20Levels%20and%20Grades.pdf.
- 33.Lambert CP, Sullivan DH, Freeling SA, Lindquist DM, and Evans WJ (2002) Effects of testosterone replacement and/or resistance exercise on the composition of megestrol acetate stimulated weight gain in elderly men: a randomized controlled trial. J Clin Endocr Metab 87:2100–2106.PubMedCrossRefGoogle Scholar
- 35.Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE, Jr., Clasey JL, Heymsfield SB, Bach MA, Vance ML, and Thorner MO (2008) Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.[Summary for patients in Ann Intern Med. 2008 Nov 4;149(9):I–36; PMID: 18981483]. Ann Intern Med 149:601–611.Google Scholar